Insmed | INSM - Créances Commerciales





Créances Commerciales Changement Date
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Cytokinetics USD 17.76M 15.96M 2025-12
DBV Technologies USD 15.97M 279K 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 158M 45.46M 2025-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03